Single-cell transcriptomics reveals immune suppression and cell states predictive of patient outcomes in rhabdomyosarcoma.
J. DeMartino, M. T. Meister, L. Visser, M. Brok, M. J. A. Groot Koerkamp, L. S. Hiemcke-Jiwa, T. de Souza, J. Merks, F. C. Holstege, T. Margaritis, J. Drost
This study uses single-cell transcriptomics to identify immune suppression and cell states in rhabdomyosarcoma that predict patient outcomes.
bioRxiv · Jul 15, 2022 · PreprintCancer Biology